Eden Research plc (LON:EDEN – Get Free Report) shares rose 16.2% on Tuesday after an insider bought additional shares in the company. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 4.18 ($0.05). Approximately 11,679,602 shares traded hands during mid-day trading, an increase of 643% from the average daily volume of 1,571,173 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey purchased 540,540 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($26,902.58).
Eden Research Price Performance
The firm has a fifty day moving average of GBX 3.88 and a 200 day moving average of GBX 4.01. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.25. The company has a market capitalization of £19.73 million, a P/E ratio of -200.00 and a beta of 0.92.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Read More
- Five stocks we like better than Eden Research
- The How and Why of Investing in Gold Stocks
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is a Low P/E Ratio and What Does it Tell Investors?
- What Does the Future Hold for Eli Lilly?
- Best Stocks Under $10.00
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
